The efficacy of bortezomib during induction therapy in patients with high-risk acute lymphoblastic leukemia by Camila Terreros-Palacios, Daniela Pérez-Sámano, Adán G. Gallardo-Rodríguez, Irma Olarte-Carrillo, Carlos Martínez-Murillo, Gilberto I. Barranco-Lampon, Christian Ramos-Peñafiel

Get full text